Jon Chick Email & Phone Number

-Strategic leadership of multiple global cross-functional Project teams in early oncology development-Empowered Teams to effectively translate project strategies into viable Target Product Profiles, business case and clinical plans as well as ensuring gating of resource utilisation through thorough scenario and option planning-Achieved accelerated Entry-into-Human and other milestones for several novel development molecules-Delivered timely go/no-go recommendations to senior… Show more -Strategic leadership of multiple global cross-functional Project teams in early oncology development-Empowered Teams to effectively translate project strategies into viable Target Product Profiles, business case and clinical plans as well as ensuring gating of resource utilisation through thorough scenario and option planning-Achieved accelerated Entry-into-Human and other milestones for several novel development molecules-Delivered timely go/no-go recommendations to senior decision making bodies enabling prioritisation of portfolio spend- Enhanced interface between Discovery and Translational Medicine to optimise decision making and cross-functional input at local portfolio and translational workstream reviews during assignment to Roche Glycart, Zurich Show less

- Successfully lead and managed cross-functional multi-site Project Team from initial concept to sNDA filing resulting in label change and key publication- Devised and coordinated global early clinical development of several oncology drugs from entry into humans to go/no-go decisions- Motivated leadership and management of International Clinical Trials group- In-depth data review, analysis and presentation to senior management and global advisory boards

Project-based contracts with Pharmaceutical/Biotech companies specialising in oncology

- Protocol writing, Project Management, analysis and reporting of Phase I/II oncology studies- Short-term assignment to oncology group at corporate headquarters in Indianapolis

- Set-up and monitoring of Phase II/III oncology studies- Protocol writing, analysis and reporting of local Phase II oncology studies